# Impact of Fermented Soy Beverages Containing Selected Vaginal Probiotics on the In Vitro Fecal Microbiota of Post-Menopausal Women

**Authors:** Margherita D’Alessandro, Davide Gottardi, Silvia Arboleya, Guadalupe Monserrat Alvarado-Jasso, Carola Parolin, Beatrice Vitali, Rosalba Lanciotti, Miguel Gueimonde, Francesca Patrignani

PMC · DOI: 10.3390/foods14061022 · Foods · 2025-03-17

## TL;DR

This study explores how fermented soy drinks with vaginal probiotics affect gut bacteria in post-menopausal women.

## Contribution

It is the first to examine the impact of L. crispatus BC4 and L. gasseri BC9 on gut microbiota in post-menopausal women.

## Key findings

- BC4 and BC9 influenced gut microbiota composition, such as increasing bifidobacteria and Ruminococcaceae in some donors.
- Encapsulated probiotics enhanced Akkermansia and short-chain fatty acid production in fecal cultures.
- Results showed significant variability among individual donors in response to the probiotic treatments.

## Abstract

The gut microbiome of women can change after menopause, and during this phase women can also be more susceptible to vaginal dysbiosis. Recent studies have explored the probiotic potential of Lactobacillus crispatus BC4 and Lactobacillus gasseri BC9 against various pathogens and their use as co-starters in foods. However, their effects on the gut microbiota of post-menopausal women, who are more prone to dysbiosis, have not been examined. This study investigated the effects of predigested soy beverages (INFOGEST) containing BC4 and BC9 (encapsulated or not) on the composition and metabolic activity of the gut microbiota in post-menopausal women, using a fecal batch culture model. Parameters such as pH, gas, SCFAs, and microbiota composition (targeted qPCR and 16S rRNA gene sequencing) were assessed. The study, while highlighting a strong variability among donors, showed differences in gut microbiota response to the tested products. For instance, donor 2 showed a significant increase in bifidobacteria with BC4 + BC9 and E-BC9, while BC4 increased Ruminococcaceae in donors 1 and 3, and E-BC4 and E-BC9 enhanced Akkermansia in donor 1. BC4, E-BC4, E-BC9, and E-BC4 + BC9 significantly impacted metabolic activity, as measured by SCFAs, compared to other samples. However, no significant differences in gas production were observed.

## Linked entities

- **Species:** Bifidobacterium (taxon 1678), Akkermansia (taxon 239934)

## Full-text entities

- **Diseases:** dysbiosis (MESH:D064806)
- **Chemicals:** BC4 (-), SCFAs (MESH:D005232)
- **Species:** Homo sapiens (human, species) [taxon 9606], gut metagenome (species) [taxon 749906]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11942071/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11942071/full.md

## References

83 references — full list in the complete paper: https://tomesphere.com/paper/PMC11942071/full.md

---
Source: https://tomesphere.com/paper/PMC11942071